Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

62.99 +1.53 (+2.49%)
Streaming Delayed Price Updated: 12:14 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Guardant Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human... 
Via MarketMinute
Topics Artificial Intelligence Derivatives
Stocks making big moves yesterday: Beyond Meat, The Trade Desk, Guardant Health, PayPal, and Tilray
Check out the companies making headlines yesterday: 
Via StockStory
Topics Cannabis Government
Why Guardant Health (GH) Stock Is Trading Up Today
Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 1.6% in the morning session after the U.S. Food and Drug Administration (FDA) approved its Guardant360® CDx blood test as a companion... 
Via StockStory
Earnings Scheduled For July 30, 2025
 
Via Benzinga
Guardant Health (GH) Stock Trades Up, Here Is Why
Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 5.2% in the morning session after the company announced a collaboration with Quest Diagnostics and provided an upbeat financial outlook... 
Via StockStory
Topics Artificial Intelligence
3 Reasons to Avoid GH and 1 Stock to Buy Instead
Guardant Health’s 28.8% return over the past six months has outpaced the S&P 500 by 13.3%, and its stock price has climbed to $60.20 per share. This was partly due to its solid quarterly results, and... 
Via StockStory
Topics Bankruptcy Stocks
Guardant Health (GH) Stock Is Up, What You Need To Know
Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 1.2% in the afternoon session after multiple financial analysts issued positive ratings on the stock. Canaccord Genuity reaffirmed its... 
Via StockStory
Topics Artificial Intelligence Economy
3 Small-Cap Stocks We Approach with Caution
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
Testing & Diagnostics Services Q2 Earnings: Guardant Health (NASDAQ:GH) is the Best in the Biz
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q2, starting... 
Via StockStory
Q2 Earnings Recap: Guardant Health (NASDAQ:GH) Tops Testing & Diagnostics Services Stocks
Looking back on testing & diagnostics services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Guardant Health (NASDAQ:GH) and its peers. 
Via StockStory
3 Unpopular Stocks with Warning Signs
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
Select Medical, Guardant Health, Artivion, PacBio, and Intuitive Surgical Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
Via StockStory
Topics Economy Stocks
Why Guardant Health (GH) Shares Are Plunging Today
Shares of diagnostics company Guardant Health (NASDAQ:GH) fell 7.1% in the morning session after the company announced updated clinical results for its Shield blood-based colorectal cancer screening... 
Via StockStory
Topics Economy
Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run
The company is working on a second version of its colon cancer screening test, Shield. 
Via Investor's Business Daily
3 Cash-Burning Stocks Walking a Fine Line
Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even... 
Via StockStory
Topics Bankruptcy
Astrana Health, agilon health, Guardant Health, AdaptHealth, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy Initial Public Offering
GH Q2 Deep Dive: Strong Volume Growth and Product Expansion Amid Profitability Challenges
Via StockStory
3 Russell 2000 Stocks We Keep Off Our Radar
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the... 
Via StockStory
Applovin, Sunrun, Duolingo, Tutor Perini, Installed Building Products And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Discover the top movers in Thursday's pre-market session.
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Stay updated with the stocks that are on the move in today's after-hours session.
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
Guardant Health Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Earnings
Via Benzinga
Guardant Health (GH) Q2 Revenue Up 31%
Via The Motley Fool
Guardant Health (NASDAQ:GH) Beats Expectations in Strong Q2, Guides for Strong Full-Year Sales
Diagnostics company Guardant Health (NASDAQ:GH) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 30.9% year on year to $232.1 million. The company’s full-year revenue guidance of... 
Via StockStory
Guardant Health (GH) Q2 Earnings: What To Expect
Diagnostics company Guardant Health (NASDAQ:GH) will be reporting results this Wednesday after the bell. Here’s what to expect. 
Via StockStory
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics
Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation. 
Via Benzinga
1 Healthcare Stock with Solid Fundamentals and 2 We Avoid
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID... 
Via StockStory
Topics Stocks
1 Volatile Stock to Own for Decades and 2 We Brush Off
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.